460 related articles for article (PubMed ID: 25457203)
1. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
[TBL] [Abstract][Full Text] [Related]
2. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
Cano A; Buqué X; Martínez-Uña M; Aurrekoetxea I; Menor A; García-Rodríguez JL; Lu SC; Martínez-Chantar ML; Mato JM; Ochoa B; Aspichueta P
Hepatology; 2011 Dec; 54(6):1975-86. PubMed ID: 21837751
[TBL] [Abstract][Full Text] [Related]
3. Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis.
Martínez-Uña M; Varela-Rey M; Cano A; Fernández-Ares L; Beraza N; Aurrekoetxea I; Martínez-Arranz I; García-Rodríguez JL; Buqué X; Mestre D; Luka Z; Wagner C; Alonso C; Finnell RH; Lu SC; Martínez-Chantar ML; Aspichueta P; Mato JM
Hepatology; 2013 Oct; 58(4):1296-305. PubMed ID: 23505042
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
5. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
6. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease.
Fernández-Tussy P; Fernández-Ramos D; Lopitz-Otsoa F; Simón J; Barbier-Torres L; Gomez-Santos B; Nuñez-Garcia M; Azkargorta M; Gutiérrez-de Juan V; Serrano-Macia M; Rodríguez-Agudo R; Iruzubieta P; Anguita J; Castro RE; Champagne D; Rincón M; Elortza F; Arslanow A; Krawczyk M; Lammert F; Kirchmeyer M; Behrmann I; Crespo J; Lu SC; Mato JM; Varela-Rey M; Aspichueta P; Delgado TC; Martínez-Chantar ML
Mol Metab; 2019 Nov; 29():40-54. PubMed ID: 31668391
[TBL] [Abstract][Full Text] [Related]
7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
9. Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase.
Yang MH; Li WY; Wu CF; Lee YC; Chen AY; Tyan YC; Chen YA
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077467
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease.
Pacana T; Cazanave S; Verdianelli A; Patel V; Min HK; Mirshahi F; Quinlivan E; Sanyal AJ
PLoS One; 2015; 10(8):e0136822. PubMed ID: 26322888
[TBL] [Abstract][Full Text] [Related]
11. Niacin increases diet-induced hepatic steatosis in B6129 mice.
Fang H; Li Z; Graff EC; McCafferty KJ; Judd RL
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158731. PubMed ID: 32404278
[TBL] [Abstract][Full Text] [Related]
12. Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
Zubiete-Franco I; García-Rodríguez JL; Martínez-Uña M; Martínez-Lopez N; Woodhoo A; Juan VG; Beraza N; Lage-Medina S; Andrade F; Fernandez ML; Aldámiz-Echevarría L; Fernández-Ramos D; Falcon-Perez JM; Lopitz-Otsoa F; Fernandez-Tussy P; Barbier-Torres L; Luka Z; Wagner C; García-Monzón C; Lu SC; Aspichueta P; Mato JM; Martínez-Chantar ML; Varela-Rey M
J Hepatol; 2016 Feb; 64(2):409-418. PubMed ID: 26394163
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
VerHague MA; Cheng D; Weinberg RB; Shelness GS
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
[TBL] [Abstract][Full Text] [Related]
15. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
16. Glycine
Hughey CC; Trefts E; Bracy DP; James FD; Donahue EP; Wasserman DH
J Biol Chem; 2018 Jul; 293(30):11944-11954. PubMed ID: 29891549
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.
Quinn C; Rico MC; Merali C; Merali S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216100
[TBL] [Abstract][Full Text] [Related]
18. Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway.
Zhu X; Xiong T; Liu P; Guo X; Xiao L; Zhou F; Tang Y; Yao P
Food Chem Toxicol; 2018 Apr; 114():52-60. PubMed ID: 29438776
[TBL] [Abstract][Full Text] [Related]
19. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets.
Umpleby AM; Shojaee-Moradie F; Fielding B; Li X; Marino A; Alsini N; Isherwood C; Jackson N; Ahmad A; Stolinski M; Lovegrove JA; Johnsen S; Jeewaka R Mendis AS; Wright J; Wilinska ME; Hovorka R; Bell JD; Thomas EL; Frost GS; Griffin BA
Clin Sci (Lond); 2017 Nov; 131(21):2561-2573. PubMed ID: 28923880
[TBL] [Abstract][Full Text] [Related]
20. No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
Poulsen MK; Nellemann B; Bibby BM; Stødkilde-Jørgensen H; Pedersen SB; Grønbaek H; Nielsen S
Diabetes Obes Metab; 2018 Oct; 20(10):2504-2509. PubMed ID: 29885082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]